The Lancet Neurology
LightNews LightNews
banner
thelancetneuro.bsky.social
The Lancet Neurology
@thelancetneuro.bsky.social
1.1K followers 26 following 49 posts

The Lancet Neurology is the leading journal in clinical neurology. We publish articles and reviews that advocate change in, or illuminate, clinical practice.

🌐 https://www.thelancet.com/journals/laneur/home

Videos
Public Health 22%
Economics 19%
Posts Replies Media Videos
Pinned
thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · 24d
November issue live! Featuring a Series on intracranial aneurysms, Personal Views on issues related to Parkinson's disease, cutting-edge research on stroke risk, treatment for acute central retinal artery occlusion, & amyloid-related imaging abnormalities in Alzheimer's disease: tinyurl.com/4bt9bcjf
The Lancet Neurology, November 2025, Volume 24, Issue 11, Pages 893-986, e13
Explore the current issue of The Lancet Neurology, a monthly journal covering international issues relevant to neurologists worldwide
tinyurl.com

Reposted by The Lancet Neurology

thelancet.com
The Lancet @thelancet.com · 17d
"Politicians may forget...Communities do not."

In his latest Offline, Richard Horton reflects on the recent World Health Summit, where global health leaders grappled with the aftermath of the US' sudden withdrawal of funding from @who.int: tinyurl.com/mr3bjs85
Offline: “People have died”
The World Health Summit has proved itself the premier global health event of the year. Under the banner “Taking responsibility for health in a fragmenting world”—symbolised by a giant stage globe crac...
tinyurl.com

Reposted by The Lancet Neurology

thelancet.com
The Lancet @thelancet.com · 17d
The UK is facing a pharma exodus, driven by claims that insufficient NHS investment threatens pharmaceutical innovation.

Yet, evidence suggests that the current pharma business model prioritises shareholder profits over innovation.

Find out more in an Editorial: tinyurl.com/n4pczpzx
Quote from the Lancet's Oct 25, 2025 Editorial. Quote reads: "The dysfunctionalities of the pharma business model will not be solved by ramping up drug prices."

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · 20d
Have you listened to our latest podcast on long-term stroke risk in women yet? Check it out here: thelancetneurology.buzzsprout.com
The Lancet Neurology in conversation with
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to...
thelancetneurology.buzzsprout.com

Reposted by The Lancet Neurology

thelancet.com
The Lancet @thelancet.com · 20d
📢 Call for papers 📢

There is still time to submit to our call for papers for a special issue on neurology. Deadline: Oct 31, 2025

Find out more 👉 tinyurl.com/4fwjttu2
Comment published in The Lancet entitled "Special issue on neurology: call for papers".

Reposted by The Lancet

Reposted by The Lancet Neurology

thelancet.com
The Lancet @thelancet.com · 26d
"...the outcomes of this work will be crucially important and will accelerate the path towards a treatment for every patient."

A new Comment discusses emerging opportunities through global collaboration for Parkinson's disease: tinyurl.com/mr3b49ex
Panel listing the aims of the Global Parkinson's Genetics Program (GP2). Copyright: 2025 Published by Elsevier Ltd.

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Sep 27
'The quality of life of patients with dementia and their caregivers: important and yet inadequately assessed' - read our most recent InContext piece here:
The quality of life of patients with dementia and their caregivers: important and yet inadequately assessed
Dementia is one of the most pressing challenges for health and social care globally, with an estimated annual economic burden of £42 billion in the UK alone. The specific toll on individuals and…
tinyurl.com

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Sep 25
A new 3-part series on the new advances in Alzheimer's disease research has just been published by @thelancet.com. Check it out here: tinyurl.com/2ubpaap3
The Lancet Series on Alzheimer’s disease
The initial successes of anti-amyloid β monoclonal antibodies offer new perspectives for improving the clinical trajectory of Alzheimer’s disease for the first time since its identification in 1906.
tinyurl.com

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Sep 25
Online First: A Review on blood and CSF biomarkers for multiple sclerosis. Check it out: tinyurl.com/3v2s2ycr
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications
Neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), chitinase-3-like protein 1 (CHI3L1), and other protein assays are being developed as diagnostic or prognostic biomarkers in mul...
tinyurl.com

Reposted by The Lancet Neurology, The Lancet Global Health

thelancet.com
The Lancet @thelancet.com · Sep 24
Pledges have been made to tackle the growing burden of non-communicable diseases (NCDs) & mental health conditions—but financing has not followed.

Ahead of the #UNGA high-level meeting on NCDs, explore 7 key actions to improve financing & health outcomes: tinyurl.com/49vnsxad @lancetgh.bsky.social
Financing policies to sustain improved prevention, control, and management of non-communicable diseases and mental health conditions
All countries have pledged to tackle the growing burden of non-communicable diseases and mental health conditions, but financing has not followed. This Health Policy summarises the background research...
tinyurl.com

Reposted by The Lancet Neurology

thelancet.com
The Lancet @thelancet.com · Sep 24
📢 Join our webinar on reporting race and ethnicity data in research

📆 Oct 23, 11am BST
👉 Register: hubs.li/Q03GrSg00

Our editors will guide you through our requirements for reporting race and ethnicity in your research, and share practical tips for all article types.
Join our webinar on reporting race and ethnicity data in research, taking place October 23, 2025. Copyright: Elsevier Ltd.

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Sep 22
New Podcast Alert! 🎵 Listen to Shiv Saidha talking about recent updates in the diagnosis of multiple sclerosis:
Multimedia | Podcasts | In conversation with | The Lancet Neurology
tinyurl.com

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Sep 19
Online First: A Comment about the promises, hopes, and dreams of Parkinson's disease:
Promises, hopes, and dreams in Parkinson's disease research
Since James Parkinson first described his eponymous disease, our knowledge of its pathophysiology has grown enormously. However, in clinical settings, many of the original concepts remain in use, and…
tinyurl.com

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Sep 19
Our October issue is out - featuring biomarkers for sudden unexpected death in epilepsy, developments in the diagnosis of multiple sclerosis, climate change & brain health and much more!

Check it out here: tinyurl.com/3z5u36e7

#Neurology #BrainHealth

Reposted by The Lancet Neurology

thelancet.com
The Lancet @thelancet.com · Sep 19
Non-communicable diseases (NCDs) include cancers, cardiovascular diseases, diabetes, immune disorders, and more.

What progress has been made in NCDs since the early 2000s?

In our latest issue, a new global analysis explores this question: tinyurl.com/mszsxer8

Full issue in thread 🧵
Cover of The Lancet's Sept 20, 2025 issue. Cover quote reads: "From 2010 to 2019, NCD mortality declined in four of every five countries in the world. These improvements were not as large as the preceding decade for most countries..."

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Sep 18
The temporal order of genetic, environmental, and pathological risk factors in Parkinson's disease - read about it here: tinyurl.com/22uk86f8
The temporal order of genetic, environmental, and pathological risk factors in Parkinson's disease: paving the way to prevention
Genetics research in Parkinson's disease has identified over 100 risk loci, yet translating these findings into understanding of disease mechanisms, clinical and pathological heterogeneity, and diseas...
tinyurl.com

Reposted by The Lancet

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Sep 9
If you haven't read it yet, we encourage you to check out this Review on the relevance of primary cilia in neurological disorders, featured in our most recent issue: tinyurl.com/2pdzssdv

#neurology #🧠
The relevance of primary cilia in neurological disorders
Primary cilia are ubiquitous organelles, which play essential roles in sensing and transducing cellular signals and in mediating key developmental pathways. Pathogenic variants in genes encoding for c...
tinyurl.com

Reposted by The Lancet Neurology

thelancet.com
The Lancet @thelancet.com · Sep 9
"Who or what is responsible for a person risking their life to cross the Channel in a boat that is barely seaworthy?...All of us."

Richard Horton's latest Offline: Help us, please tinyurl.com/52zfck7b
Offline: Help us, please
“We all become monsters when History gives us the opportunity”, writes Olivier Norek in his novel about migrants and traffickers, Between Two Worlds. One of the malicious absurdities about political a...
tinyurl.com

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Aug 27
Have you ever wondered who invented the EEG? You will find the answer in this short Focal Point: tinyurl.com/59e87nzn
Hans Berger and the EEG
Hans Berger (1873–1941), a professor of psychiatry at the University of Jena, in Germany, who collaborated with the Nazi regime, is regarded as the father of EEG.1 As an adolescent, he borrowed a book...
tinyurl.com

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Aug 19
👂Podcast alert!! Listen to our our conversation with Professor Michael Rafii about Down syndrome-related Alzheimer's disease here: tinyurl.com/59nvbxam

#DownSyndrome #AlzheimersDisease #Neurology
Multimedia | Podcasts | In conversation with | The Lancet Neurology
tinyurl.com

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Aug 15
🧠 This month, we're diving into why neurorehabilitation must put patients first—discover why a patient-centred approach matters! Read our editorial: tinyurl.com/5n7atrd5

Plus: Our featured Insight explores how neurorehabilitation could lead the shift toward systems medicine: tinyurl.com/yjjhah4b
Neurorehabilitation as a cornerstone of recovery
An estimated 3·4 billion people worldwide live with a neurological disease or the consequences of acquired brain injuries, including stroke, traumatic brain injury, and spinal cord injury. Neurologica...
tinyurl.com

Reposted by The Lancet Oncology, The Lancet Neurology

thelancet.com
The Lancet @thelancet.com · Aug 14
“The world cannot afford another crisis in which lives are lost not for lack of vaccines, but for lack of truth.”

A new Comment on the global cost of US vaccine misinformation: bit.ly/3Uu7b5o
A crisis of credibility: the global cost of US vaccine misinformation
The global health community faces a deepening challenge—not only from infectious diseases but also from a pandemic of misinformation.1 The USA, long a cornerstone of global health leadership, has beco...
www.thelancet.com

Reposted by The Lancet

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Aug 14
🧠Our September issue is live!

This month:
🔬Primary cilia in neurological disorders
🧬Down syndrome & Alzheimer's: biomarkers, clinical symptoms & pathology
💪Advances in management of idiopathic inflammatory myopathies

And much more about brain health, diagnostics treatment: tinyurl.com/yc365yh8
The Lancet Neurology, September 2025, Volume 24, Issue 9, Pages 713-800, e11
Explore the current issue of The Lancet Neurology, a monthly journal covering international issues relevant to neurologists worldwide
tinyurl.com

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Aug 11
Will MR-guided focused ultrasound play an important role in the future treatment of patients with movement disorders and neurodegenerative diseases? According to the Personal View published in our latest issue, it is a therapeutic approach worth paying attention to! tinyurl.com/anezynz7

thelancetneuro.bsky.social
The Lancet Neurology @thelancetneuro.bsky.social · Aug 8
With the global burden of neurological disease and acquired brain injury rising, neurorehabilitation becomes ever more important. An article published in our last issue, tests the safety and and effectiveness of the Walk ‘n Watch exercise protocol for stroke rehabilitation: tinyurl.com/y4sjwbf7